Am. Gurvitch et al., PROPHYLAXIS OF ENCEPHALOPATHIES AND RISK-FACTORS OF ATHEROGENESIS DEVELOPMENT IN THE POSTRESUSCITATION PERIOD IN RATS BY MEANS OF SUCCINIC ACID, Resuscitation, 35(2), 1997, pp. 165-170
The effect of oral administration of succinic acid was studied in 66 r
ats exposed to 10 min cardiac arrest with further resuscitation. A tot
al of 30 mg/kg of the drug were administered daily for 5 days starting
with day 3 up to day 7 after resuscitation. The experiments have reve
aled that treatment with succinic acid caused normalization of the ori
enting behavior in an 'open field' test, decrease of the intensity of
response to electric shock, normalization of free radical formation in
the brain and serum and reduced cerebral morphological changes. The s
uccinic acid prevented the increase of cholesterol, triglyceride and l
ow density lipoproteins in the blood. The data suggested that after ad
ditional trials the succinic acid could be used to prevent development
of postresuscitation encephalopathies (3 months after reanimation). (
C) 1997 Elsevier Science Ireland Ltd.